Join
Live feed
·
PRReleasevia Quantisnow
Exact Sciences Corporation logo

The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study

ByQuantisnow·Wall Street's wire, on your screen.
EXAS· Exact Sciences Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EXAS (Exact Sciences Corporation) and more on Quantisnow.